UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Annals of oncology, 2006-06, Vol.17 (6), p.935-944

2006

Volltextzugriff (PDF)

Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials

Annals of oncology, 2012-11, Vol.23 (11), p.2843-2851

2012

Volltextzugriff (PDF)

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

Annals of oncology, 2011-10, Vol.22 (10), p.2201-2207

2011

Volltextzugriff (PDF)

Symptoms of endocrine treatment and outcome in the BIG 1-98 study

Breast cancer research and treatment, 2014-01, Vol.143 (1), p.159-169

2014

Volltextzugriff (PDF)

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

Annals of oncology, 2004-06, Vol.15 (6), p.875-884

2004

Volltextzugriff (PDF)

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials

Annals of oncology, 2007-04, Vol.18 (4), p.701-708

2007

Volltextzugriff (PDF)

5016 POSTER DISCUSSION BIG 1-98 Update: Evaluating Letrozole and Tamoxifen Alone and in Sequence at 8 Years Median Follow-up for Postmenopausal Women With Steroid Hormone Receptor-Positive Breast Cancer

European journal of cancer (1990), 2011, Vol.47, p.S334-S335

2011

Volltextzugriff (PDF)

Racial and ethnic disparities in global atopic dermatitis clinical trials

British journal of dermatology (1951), 2020-08, Vol.183 (2), p.378-380

2020

Volltextzugriff (PDF)

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Annals of oncology, 2009-09, Vol.20 (9), p.1489-1498

2009

Volltextzugriff (PDF)

353 Safety of letrozole and tamoxifen monotherapy: updated BIG 1-98

European journal of cancer supplements, 2010, Vol.8 (3), p.160-160

2010

Volltextzugriff (PDF)

Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

Annals of oncology, 2007-05, Vol.18 (5), p.859-867

2007

Volltextzugriff (PDF)

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

Annals of oncology, 2012-11, Vol.23 (11), p.2852-2858

2012

Volltextzugriff (PDF)

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial

Annals of oncology, 2015-12, Vol.26 (12), p.2442-2449

2015

Volltextzugriff (PDF)

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

Annals of oncology, 2011-09, Vol.22 (9), p.1981-1987

2011

Volltextzugriff (PDF)

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

Annals of oncology, 2011-10, Vol.22 (10), p.2216-2226

2011

Volltextzugriff (PDF)

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer

British journal of cancer, 2012-05, Vol.106 (10), p.1618-1625

2012

Volltextzugriff (PDF)

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

Annals of oncology, 2008-07, Vol.19 (7), p.1231-1241

2008

Volltextzugriff (PDF)

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

Annals of oncology, 2012-05, Vol.23 (5), p.1138-1144

2012

Volltextzugriff (PDF)

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer

Annals of oncology, 2010-02, Vol.21 (2), p.245-254

2010

Volltextzugriff (PDF)

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer

Annals of oncology, 2008-08, Vol.19 (8), p.1393-1401

2008

Volltextzugriff (PDF)

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up

Annals of oncology, 2009-08, Vol.20 (8), p.1344-1351

2009

Volltextzugriff (PDF)

p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer

Annals of oncology, 2008-04, Vol.19 (4), p.660-668

2008

Volltextzugriff (PDF)

Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor

Annals of oncology, 2005-05, Vol.16 (5), p.716-725

2005

Volltextzugriff (PDF)

Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11–93

Breast (Edinburgh), 2001-08, Vol.10, p.130-138

2001

Volltextzugriff (PDF)

Preparation of cyclic amines by intramolecular carbolithiation (BL)

Price, K.N

2001

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(43)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(20)
British Journal Of Cancer
(2)
Plos Pathogens
(2)
The Lancet
(2)
Analytical Chemistry
(1)
Breast
(1)
Breast Cancer Research And Treatment
(1)
British Journal Of Dermatology
(1)
Cell Reports
(1)
Environmental Entomology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

Symptoms of endocrine treatment and outcome in the BIG 1-98 study

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials

5016 POSTER DISCUSSION BIG 1-98 Update: Evaluating Letrozole and Tamoxifen Alone and in Sequence at 8 Years Median Follow-up for Postmenopausal Women With Steroid Hormone Receptor-Positive Breast Cancer

Racial and ethnic disparities in global atopic dermatitis clinical trials

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

353 Safety of letrozole and tamoxifen monotherapy: updated BIG 1-98

Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up

p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer

Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor

Preparation of cyclic amines by intramolecular carbolithiation (BL)

Suchergebnisse filtern